Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

This activity was originally broadcast in conjunction with AMCP 2025.

Program Description

Respiratory syncytial virus (RSV) poses a significant health threat to older adults, contributing to substantial morbidity, hospitalizations, and health care costs annually. Prevention strategies have become a critical focus in clinical practice to reduce morbidity and mortality in older adults. Recently approved vaccines represent new approaches to reduce the burden of RSV-related complications. This program will provide an in-depth look at the pathology, clinical manifestations, and impact on public health of RSV, while highlighting the efficacy, safety, and cost-effectiveness of available vaccines for RSV. Managed care professionals will gain actionable strategies to implement ACIP recommendations, promote equitable access to RSV vaccination, and reduce health care resource utilization.

Target audience: Managed care pharmacists

Type of activity: Application
Release date: April 10, 2025
Expiration date: April 10, 2026

Time to complete activity: 1.5 hours

Learner level: Foundational
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine the economic and clinical burden of respiratory syncytial virus (RSV) lower respiratory tract disease.
• Analyze the latest clinical data for recently approved and emerging vaccines for RSV.
• Identify managed care initiatives to facilitate the uptake of new RSV immunization strategies to reduce the impact of RSV in adults and on the health care system.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-25-083-H01-P. The activity is available for CE credit through April 10, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Faculty

Jeff Goad, PharmD, MPH, has the following relevant financial relationships with commercial interests to disclose: Consultant: Merck, Moderna, Valneva; Speakers Bureau: Merck, Moderna.

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Abby Singleton, PharmD, BCPS

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Liza Patel, PharmD; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms